Year |
Citation |
Score |
2022 |
Suzuki M, Jeng LJB, Chefo S, Wang Y, Price D, Li X, Wang J, Li RJ, Ma L, Yang Y, Zhang X, Zheng N, Zhang K, Joseph DB, Shroff H, et al. FDA approval summary for lonafarnib (Zokinvy) for the treatment of Hutchinson-Gilford progeria syndrome and processing-deficient progeroid laminopathies. Genetics in Medicine : Official Journal of the American College of Medical Genetics. PMID 36507973 DOI: 10.1016/j.gim.2022.11.003 |
0.394 |
|
2022 |
Duke ES, Stapleford L, Drezner N, Amatya AK, Mishra-Kalyani PS, Shen YL, Maxfield K, Fourie Zirkelbach J, Bi Y, Liu J, Zhang X, Wang H, Yang Y, Zheng N, Reece K, et al. FDA Approval Summary: Mobocertinib for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 36112541 DOI: 10.1158/1078-0432.CCR-22-2072 |
0.384 |
|
2021 |
Xiong Y, Fan J, Kitabi E, Zhang X, Bi Y, Grimstein M, Yang Y, Earp JC, Zheng N, Liu J, Wang Y, Zhu H. Model Informed Drug Development Approaches to Assist New Drug Development in the COVID-19 Pandemic. Clinical Pharmacology and Therapeutics. PMID 34807992 DOI: 10.1002/cpt.2491 |
0.414 |
|
2020 |
Fan J, Zhang X, Liu J, Yang Y, Zheng N, Liu Q, Bergman K, Reynolds K, Huang SM, Zhu H, Wang Y. Connecting hydroxychloroquine in vitro antiviral activity to in vivo concentration for prediction of antiviral effect: a critical step in treating COVID-19 patients. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32435791 DOI: 10.1093/cid/ciaa623 |
0.386 |
|
2018 |
Singh H, Walker AJ, Amiri-Kordestani L, Cheng J, Tang S, Balcazar P, Barnett-Ringgold K, Palmby TR, Cao X, Zheng N, Liu Q, Yu J, Pierce WF, Daniels SR, Sridhara R, et al. U.S. Food and Drug Administration Approval: Neratinib for the Extended Adjuvant Treatment of Early Stage HER2-Positive Breast Cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 29523624 DOI: 10.1158/1078-0432.CCR-17-3628 |
0.371 |
|
2015 |
Jiang W, Makhlouf F, Schuirmann DJ, Zhang X, Zheng N, Conner D, Yu LX, Lionberger R. Erratum to: A Bioequivalence Approach for Generic Narrow Therapeutic Index Drugs: Evaluation of the Reference-Scaled Approach and Variability Comparison Criterion. The Aaps Journal. PMID 25975618 DOI: 10.1208/s12248-015-9786-9 |
0.399 |
|
2015 |
Jiang W, Makhlouf F, Schuirmann DJ, Zhang X, Zheng N, Conner D, Yu LX, Lionberger R. A Bioequivalence Approach for Generic Narrow Therapeutic Index Drugs: Evaluation of the Reference-Scaled Approach and Variability Comparison Criterion. The Aaps Journal. 17: 891-901. PMID 25840883 DOI: 10.1208/s12248-015-9753-5 |
0.425 |
|
2013 |
Rosania GR, Shedden K, Zheng N, Zhang X. Visualizing chemical structure-subcellular localization relationships using fluorescent small molecules as probes of cellular transport. Journal of Cheminformatics. 5: 44. PMID 24093553 DOI: 10.1186/1758-2946-5-44 |
0.658 |
|
2013 |
Zhang X, Zheng N, Lionberger RA, Yu LX. Innovative approaches for demonstration of bioequivalence: the US FDA perspective. Therapeutic Delivery. 4: 725-40. PMID 23738669 DOI: 10.4155/tde.13.41 |
0.423 |
|
2012 |
Yu JY, Zheng N, Mane G, Min KA, Hinestroza JP, Zhu H, Stringer KA, Rosania GR. A cell-based computational modeling approach for developing site-directed molecular probes. Plos Computational Biology. 8: e1002378. PMID 22383866 DOI: 10.1371/Journal.Pcbi.1002378 |
0.706 |
|
2011 |
Zheng N, Tsai HN, Zhang X, Rosania GR. The subcellular distribution of small molecules: from pharmacokinetics to synthetic biology. Molecular Pharmaceutics. 8: 1619-28. PMID 21805990 DOI: 10.1021/Mp200092V |
0.695 |
|
2011 |
Zheng N, Tsai HN, Zhang X, Shedden K, Rosania GR. The subcellular distribution of small molecules: a meta-analysis. Molecular Pharmaceutics. 8: 1611-8. PMID 21774504 DOI: 10.1021/Mp200093Z |
0.669 |
|
2011 |
Zheng N, Zhang X, Rosania GR. Effect of phospholipidosis on the cellular pharmacokinetics of chloroquine. The Journal of Pharmacology and Experimental Therapeutics. 336: 661-71. PMID 21156819 DOI: 10.1124/Jpet.110.175679 |
0.668 |
|
2010 |
Zhang X, Zheng N, Zou P, Zhu H, Hinestroza JP, Rosania GR. Cells on pores: A simulation-driven analysis of transcellular small molecule transport Molecular Pharmaceutics. 7: 456-467. PMID 20025248 DOI: 10.1021/Mp9001969 |
0.672 |
|
2008 |
Zhang X, Zheng N, Rosania GR. Simulation-based cheminformatic analysis of organelle-targeted molecules: Lysosomotropic monobasic amines Journal of Computer-Aided Molecular Design. 22: 629-645. PMID 18338229 DOI: 10.1007/S10822-008-9194-7 |
0.69 |
|
Show low-probability matches. |